Pharmaceutical Manufacturing - Global Market Outlook (2018-2027)

   |      |      |  

Pharmaceutical Manufacturing - Global Market Outlook (2018-2027)

"The Global Pharmaceutical Manufacturing Market is expected to grow at a CAGR of 7.0% during the forecast period. Increasing prevalence of chronic diseases and the growing demand for medications are the major factors propelling the market growth. However, high initial cost and stringent government regulations are restraining the market growth.

Pharmaceutical manufacturing is the procedure of drug manufacturing and can be broken to a sequence of unit actions, such as milling, granulation, coating, tableting, and others. The Pharmaceutical manufacturing process has precise requirements and manufacturing guidelines in terms of quality.

Based on the formulation, the injectables segment is having a lucrative growth during the forecast period due to the ongoing researches for developing new drugs and the growing use of sterile products in medical sector. By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to owing to less cost, healthier way of life, higher disposal incomes, growth of generics, high efficiency and low cost of labour.

Some of the key players profiled in the Pharmaceutical Manufacturing Market include Takeda, Sanofi, Roche, Pfizer, Novo Nordisk, Novartis, Lupin, GlaxoSmithKline, Gilead Sciences, Eli Lily, Merck & Co., Cipla, Astra Zeneca, Amgen, Actavis and Abbott Laboratories.

Formulations Covered:
• Tablets
• Syrups
• Suspensions
• Powders
• Injectables
• Emulsions
• Capsules

Route of Administrations Covered:
• Topical
• Parenteral
• Oral
• Inhalations
• Enteral

Prescription Requirements Covered:
• OTC (Over the Counter) Medicines
• Prescription Medicines

Diseases Covered:
• Respiratory Disease Treatment
• Renal
• Neurological
• Cardiovascular
• Cancer

End Users Covered:
• Pregnant Women
• Pediatrics
• Neonates
• Geriatrics
• Adults

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pharmaceutical Manufacturing Market, By Formulation
5.1 Introduction
5.2 Tablets
5.3 Syrups
5.4 Suspensions
5.5 Powders
5.6 Injectables
5.7 Emulsions
5.8 Capsules

6 Global Pharmaceutical Manufacturing Market, By Route of Administration
6.1 Introduction
6.2 Topical
6.3 Parenteral
6.4 Oral
6.5 Inhalations
6.6 Enteral

7 Global Pharmaceutical Manufacturing Market, By Prescription Requirement
7.1 Introduction
7.2 OTC (Over the Counter) Medicines
7.3 Prescription Medicines

8 Global Pharmaceutical Manufacturing Market, By Disease
8.1 Introduction
8.2 Respiratory Disease Treatment
8.3 Renal
8.4 Neurological
8.5 Cardiovascular
8.6 Cancer

9 Global Pharmaceutical Manufacturing Market, By End User
9.1 Introduction
9.2 Pregnant Women
9.3 Pediatrics
9.4 Neonates
9.5 Geriatrics
9.6 Adults

10 Global Pharmaceutical Manufacturing Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Takeda
12.2 Sanofi
12.3 Roche
12.4 Pfizer
12.5 Novo Nordisk
12.6 Novartis
12.7 Lupin
12.8 GlaxoSmithKline
12.9 Gilead Sciences
12.10 Eli Lily Merck & Co
12.11 Cipla
12.12 Astra Zeneca
12.13 Amgen
12.14 Actavis
12.15 Abbott Laboratories

List of Tables
Table 1 Global Pharmaceutical Manufacturing Market Outlook, By Region (2017-2027) (US $MN)
Table 2 Global Pharmaceutical Manufacturing Market Outlook, By Formulation (2017-2027) (US $MN)
Table 3 Global Pharmaceutical Manufacturing Market Outlook, By Tablets (2017-2027) (US $MN)
Table 4 Global Pharmaceutical Manufacturing Market Outlook, By Syrups (2017-2027) (US $MN)
Table 5 Global Pharmaceutical Manufacturing Market Outlook, By Suspensions (2017-2027) (US $MN)
Table 6 Global Pharmaceutical Manufacturing Market Outlook, By Powders (2017-2027) (US $MN)
Table 7 Global Pharmaceutical Manufacturing Market Outlook, By Injectables (2017-2027) (US $MN)
Table 8 Global Pharmaceutical Manufacturing Market Outlook, By Emulsions (2017-2027) (US $MN)
Table 9 Global Pharmaceutical Manufacturing Market Outlook, By Capsules (2017-2027) (US $MN)
Table 10 Global Pharmaceutical Manufacturing Market Outlook, By Route of Administration (2017-2027) (US $MN)
Table 11 Global Pharmaceutical Manufacturing Market Outlook, By Topical (2017-2027) (US $MN)
Table 12 Global Pharmaceutical Manufacturing Market Outlook, By Parenteral (2017-2027) (US $MN)
Table 13 Global Pharmaceutical Manufacturing Market Outlook, By Oral (2017-2027) (US $MN)
Table 14 Global Pharmaceutical Manufacturing Market Outlook, By Inhalations (2017-2027) (US $MN)
Table 15 Global Pharmaceutical Manufacturing Market Outlook, By Enteral (2017-2027) (US $MN)
Table 16 Global Pharmaceutical Manufacturing Market Outlook, By Prescription Requirement (2017-2027) (US $MN)
Table 17 Global Pharmaceutical Manufacturing Market Outlook, By OTC (Over the Counter) Medicines (2017-2027) (US $MN)
Table 18 Global Pharmaceutical Manufacturing Market Outlook, By Prescription Medicines (2017-2027) (US $MN)
Table 19 Global Pharmaceutical Manufacturing Market Outlook, By Disease (2017-2027) (US $MN)
Table 20 Global Pharmaceutical Manufacturing Market Outlook, By Respiratory Disease Treatment (2017-2027) (US $MN)
Table 21 Global Pharmaceutical Manufacturing Market Outlook, By Renal (2017-2027) (US $MN)
Table 22 Global Pharmaceutical Manufacturing Market Outlook, By Neurological (2017-2027) (US $MN)
Table 23 Global Pharmaceutical Manufacturing Market Outlook, By Cardiovascular (2017-2027) (US $MN)
Table 24 Global Pharmaceutical Manufacturing Market Outlook, By Cancer (2017-2027) (US $MN)
Table 25 Global Pharmaceutical Manufacturing Market Outlook, By End User (2017-2027) (US $MN)
Table 26 Global Pharmaceutical Manufacturing Market Outlook, By Pregnant Women (2017-2027) (US $MN)
Table 27 Global Pharmaceutical Manufacturing Market Outlook, By Pediatrics (2017-2027) (US $MN)
Table 28 Global Pharmaceutical Manufacturing Market Outlook, By Neonates (2017-2027) (US $MN)
Table 29 Global Pharmaceutical Manufacturing Market Outlook, By Geriatrics (2017-2027) (US $MN)
Table 30 Global Pharmaceutical Manufacturing Market Outlook, By Adults (2017-2027) (US $MN)


Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
"

Pharmaceutical Manufacturing - Global Market Outlook (2018-2027)

.